EXHIBIT 1.1

[CONFIDENTIAL TREATMENT REQUESTED] /*/ INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

2011 LIVESTOCK PRODUCTS DISTRIBUTION AGREEMENT

This Livestock Products Agreement (“Agreement”) effective as of January 1, 2011 (“Effective Date”) is made by and between Pfizer Inc., 5 Giralda Farms, Madison, New Jersey 07940-1027 (“Pfizer”) and Walco International, Inc., 7 Village Circle, Suite 200, Westlake, TX 76262 (hereinafter, “WALCO”).

WHEREAS, WALCO is in the business of buying and selling animal health products and servicing customers for those products, and

WHEREAS, WALCO and Pfizer wish to set forth the terms of their relationship related to the purchase and supply of such products,

NOW, THEREFORE, in consideration of the promises and covenants contained herein, the parties hereby agree as follows:

Definitions:

“PARTICIPATING CUSTOMERS” shall mean customers from the list of customers approved by Pfizer who have entered into a Leaders Edge Agreement with Pfizer.

“Products” shall mean the Pfizer cattle and swine products sold to WALCO by Pfizer pursuant to this Agreement (and referenced in Schedule A to this Agreement).

“Sales Out” shall mean the reported sales by WALCO to Covansys and accepted by Pfizer.

“Strategic Accounts” shall mean all those PARTICIPATING CUSTOMERS listed in Schedule B hereto.

1. (a) Pfizer shall continue to promote its Products to certain select customers in the livestock field. The parties agree that each time a PARTICIPATING CUSTOMER selects WALCO as their supplier and to service that customer’s account, Pfizer shall send to WALCO a Pfizer Suggested Resale Price List which shall specify the Pfizer Products and the Pfizer suggested resale prices quoted to such PARTICIPATING CUSTOMER (hereafter “SUGGESTED RESALE PRICE LIST”). Each such SUGGESTED RESALE PRICE LIST shall be incorporated into and become part of this Agreement. Please find the current SUGGESTED RESALE PRICE LIST listed on Schedule C hereto. Also included on Schedule C is the current Pfizer Livestock Distributor Pricing. The Products and suggested resale prices are subject to change at any time in Pfizer’s sole discretion upon thirty (30) days prior written notice.

(b) Pfizer reserves the right to add or delete PARTICIPATING CUSTOMERS or Strategic Accounts at any time at Pfizer’s sole discretion. Pfizer will provide written notice to WALCO of any changes. Pfizer will notify WALCO of any (i) additions to the Strategic Accounts list within twenty-four (24) hours of Pfizer’s receipt of the customer contract and (ii) removals from the Strategic Accounts list within four (4) business days prior to the removal effective date.

2. (a) WALCO represents and warrants that for the purposes of this Agreement, it is in the business of purchasing Products from Pfizer for the sole purpose of resale and distribution, is registered within the state(s) with which it does business, is compliant with all pharmacy and distribution licensing

requirements within the state(s) with which it does business, and is compliant with and capable of participating in Electronic Data Interchange (EDI).

(b) WALCO agrees to purchase from Pfizer, at credit terms agreed to between the parties and as may be further set forth on Pfizer’s invoices, Products sufficient to fulfill demand from all customers to whom WALCO will sell Products in the quantities desired by the customers.

(c) WALCO agrees to maintain an inventory of Products equal to /*/ Demand per species as identified on Schedule A Cattle and Swine, but excluding all Products indicated on Schedule A as ineligible for RSA payments. /*/

All Products shall count towards the amount held in inventory by WALCO. WALCO and Pfizer agree to act in good faith to resolve any material differences in the on hand inventory calculations.

(d) Pfizer reserves the right to allocate purchases such that WALCO may not purchase more than two (2) months WALCO’s average of the most current Moving Annual Total sales purchases. Exceptions must be approved by Pfizer’s Animal Health Headquarters.

(e) WALCO agrees that all sales of Pfizer Products from WALCO to a PARTICIPATING CUSTOMER shall reflect the specific prices for each Product provided for in that PARTICIPATING CUSTOMER’S most recent SUGGESTED RESALE PRICE LIST. In the event that the price listed on a PARTICIPATING CUSTOMER’S most recent SUGGESTED RESALE PRICE LIST for any particular Product is lower (at the time of consummation of a sale of such particular Products between WALCO and that PARTICIPATING CUSTOMER) than the price paid by WALCO to Pfizer for such Product, Pfizer agrees to credit WALCO’s account for the amount of such difference.

3. Nothing herein contained shall create or be deemed to create any relationship between the parties other than as specifically provided for herein. No employment, partnership, specific or general agency relationship shall exist unless specifically provided for in writing between the parties. WALCO shall not represent, directly or indirectly, expressly or by implication, that any such relationships exist and/or that WALCO has any authority except as set forth in this Agreement.

4. WALCO shall use commercially reasonable efforts to provide appropriate service to the customers to whom WALCO will sell hereunder. For customers serviced pursuant to this Agreement, WALCO shall:

(a) Store its inventory of Pfizer Products under conditions (including refrigeration where appropriate) in accordance with package labeling or other written instructions from Pfizer to ensure that such Products retain their potency, purity, quality, and identity;

(b) Provide to Covansys by the close of business on Friday of each week an EDI report 852 report covering all Product inventory purchased from Pfizer and setting forth in dollars at WALCO’s acquisition cost from Pfizer the amount of inventory by species. WALCO agrees that Pfizer shall have the right, upon reasonable advance notice and during business hours to audit inventory in the possession of WALCO to confirm compliance with this paragraph 4(b) and to confirm the accuracy of the data contained in the report;

(c) Provide to Covansys its Health Industry Number, Customer Health Industry Number, Pfizer Product number, transaction date, ship to zip code, number of units and price with respect to each sale of Product, and unit inventories on each Pfizer Product sku that WALCO sells;

(d) Provide Sales Out data, which shall include Leaders Edge and Non-Leaders Edge sales, to Covansys within ten (10) working days of the date of each invoice. WALCO will use its best efforts to ensure Sales Out data integrity and timeliness;

(e) Submit all orders to Pfizer via EDI. EDI report 867 is the acceptable format;

(f) Establish any service fee or other charge or discount to any customer including PARTICIPATING CUSTOMERS for Pfizer Products independently and at its sole discretion;

(g) Provide regularly scheduled delivery service to its customers and use commercially reasonable efforts to anticipate its customers’ requirements for Pfizer Products. In the event Pfizer delivers any product order to PARTICIPATING CUSTOMERS (drop ship), no consideration shall be payable to WALCO for that order under paragraph 5 below, provided that Pfizer will pay WALCO for any drop ship if such shipment is made necessary by the unavailability of Pfizer Products;

(h) WALCO agrees that credit limits established by Pfizer shall be subject to change upon written notice by Pfizer in its sole discretion and that no Product shipments will be made to WALCO in excess of the established credit limits;

(i) Invoice customers in an accurate and timely manner;

(j) Refer to that PARTICIPATING CUSTOMERS SUGGESTED RESALE PRICE LIST on each invoice for Pfizer Products;

(k) Take no action, whether or not identified above, that would harm the Goodwill or name of Pfizer, or damage the interests of Pfizer or the Products, other than where supported by sound factual evidence, including, but not limited to, the diversion of Products and statements of false information. For purposes of this Agreement “Goodwill” shall mean the marketplace advantage of customer patronage and loyalty developed with continuous business under the same name over a period of time; and

(l) /*/

5. All sales of Products to PARTICIPATING CUSTOMER or Strategic Accounts for whom a SUGGESTED RESALE PRICE LIST has been incorporated into this Agreement are covered by this Agreement with regard to compensation payable to WALCO hereunder. Any transaction involving Products with any customer including a PARTICIPATING CUSTOMER for which WALCO has not been selected by that PARTICIPATING CUSTOMER as the distributor are not covered by this Agreement with regard to compensation payable hereunder.

6. (a) WALCO shall not be provided with any rebate, discount or other compensation for Products handled under this Agreement unless specifically set forth herein. WALCO will NOT be eligible to collect an RSA on any lateral sales to an unauthorized Pfizer distributor. (It is WALCO’s obligation to confirm with Pfizer, prior to making a sale, as to whether a distributor is an authorized distributor.) All sales by Pfizer to WALCO shall be at the then current Pfizer list price but subject to appropriate credits in accordance with paragraph 2(e). Pfizer shall have the right to raise or change the price of any or all Products to WALCO on /*/ prior written notice. Pfizer shall be free to limit sales of any or all Products to WALCO in advance of any price increase.

(b) The parties agree that Pfizer shall not be obligated to issue credits for any returns that exceed the current average of returns of distributors as specified below unless such returns are the subject of a recall or made at the request of Pfizer. The current average of returns of distributors for the calendar year of the contract timeline January 1, 2011 to December 31, 2011 shall be:

/*/

7. The payments described in Schedule D hereto constitute full and complete compensation for WALCO.

8. All returns shall be approved by Pfizer and subject to Pfizer’s Returned Goods Policy, attached hereto as Schedule F. WALCO may not offset payment to Pfizer of invoice amounts as credit for any compensation payable hereunder. Pfizer shall make bi-monthly payments of appropriate fees to WALCO.

9. WALCO and Pfizer agree that, under the specific circumstances delineated in this Section 9, each party, at such party’s sole discretion, may recoup the sums outstanding to it from the other party against those sums which may become due from such party to the other party, in that the obligations arise from mutual transactions. The specific circumstances which will enable each party to initiate recoupment are:

(a) The other party becomes insolvent, which shall be defined as:

(i) the sum of the other party’s debts is greater than all of other party’s property (“Balance Sheet Test”); or

(ii) the other party is generally not paying its debts as they come due; or

(iii) the other party has failed to act in good faith for a period in excess of six (6) months to resolve any outstanding invoice or purchase order issues or reconciliations.

(b) The other party commences a liquidation of its operations by means of a sale of its assets in their entirety or piecemeal; or

(d) The other party files a proceeding pursuant to the U.S. Bankruptcy Code or any state court proceeding, including an Assignment for the Benefit of Creditors.

10. Nothing in this Agreement shall be deemed to preclude WALCO from negotiating a service fee or any other consideration from, or providing any discount or rebate to, any customer, including PARTICIPATING CUSTOMERS for any services provided by WALCO.

11. WALCO shall distribute Pfizer Products only under the labeling provided by Pfizer or as otherwise approved in writing by Pfizer; prescribe, recommend, suggest, and advertise each Product for use only under the conditions stated in the labeling provided by Pfizer; and observe all federal, state, and local laws governing the distribution of the Products.

12. Nothing in this Agreement shall be deemed to limit Pfizer’s ability to sell any Product at any time to any customer including PARTICIPATING CUSTOMERS or any other party. Transactions consummated directly between Pfizer and any such customer or other party shall not qualify for any of the compensation payable to WALCO hereunder. Nothing in this Agreement shall be deemed to limit WALCO’s ability to sell non-Pfizer products at any time to any customer including PARTICIPATING CUSTOMERS or any other party. WALCO’s active promotion or sale of products not made by Pfizer will not be considered harmful to the Goodwill or name of Pfizer, or the Products, provided that the Pfizer Products are not maligned in any way as prohibited under Section 4(k) of this Agreement.

13. EXCEPT AS SET FORTH IN THIS AGREEMENT, IN THE LABELING OF THE PRODUCTS SOLD HEREUNDER, OR AS OTHERWISE SPECIFIED IN WRITING BY PFIZER, PFIZER MAKES NO EXPRESS OR IMPLIED WARRANTIES WITH RESPECT TO THE PRODUCTS.

(a) Pfizer shall defend, indemnify, and hold WALCO harmless from all liabilities, claims, demands, damages, costs and expenses, or money judgments incurred by WALCO or rendered against it resulting from (a) any breach by Pfizer of this Agreement, (b) third party claims or actions for personal injury or property damage which arise out of the distribution or sale of Pfizer products or the failure to warn, except to the extent that such personal injury or property damage arises out of the negligence or willful misconduct of WALCO, and (c) any claim that the Products, as sold by Pfizer, were defective. In the event Pfizer is found by any court of competent jurisdiction to be liable for any claim based in products liability, then Pfizer shall reimburse WALCO’s reasonable legal fees incurred in the course of cooperating with Pfizer’s defense. To be covered by this defense and indemnity,

WALCO must: promptly notify Pfizer of any such claim; allow Pfizer to fully control the defense and/or resolution of the claim; and cooperate fully with Pfizer in the matter. This defense, indemnity and payment for legal fees shall not apply to claims alleging: WALCO alteration, negligent handling or improper storage of the Products; sale of outdated Products; sale or recommendation of the Products for uses or in a manner not set forth in either the labeling supplied by Pfizer or as otherwise specified by Pfizer in writing; or sale of the Products after receipt of written notice from Pfizer that such sales should be halted.

(b) In no event shall either party be liable to the other party for special, collateral, incidental, punitive or consequential damages in connection with or arising out of this Agreement. Except as provided under subparagraph 13(a), above, total damages recoverable against Pfizer by WALCO shall be exclusively limited to the purchase price of the Products with respect to which damages are claimed.

14. WALCO and Pfizer acknowledge that in the performance of their duties hereunder each may obtain access to “Confidential Information” (as defined below) of the other. WALCO and Pfizer agree that during the term of this Agreement and for a period of three (3) years after the termination of this Agreement, unless specifically permitted in writing by the other party, which permission shall not be unreasonably withheld, especially in connection with a sale of all or a substantial portion of WALCO’s business, to (a) retain in confidence and not disclose to any third party and (b) use only for the purpose of carrying out their duties hereunder, any such Confidential Information. As used herein the term “Confidential Information” means any information, or data, whether of a business or scientific nature and whether in written, oral or tangible form, relating to Pfizer’s and WALCO’s business or potential business or its research and development activities, not generally available to or known to the public, and not otherwise known to the receiving party, that is disclosed to or learned by the other party pursuant hereto. “Confidential information” does not mean or include any information: (a) which is, at the time of disclosure, available to the general public; or (b) which following disclosure becomes available to the general public through no fault of the recipient; or (c) which recipient can demonstrate was in its possession before receipt; or (d) which is disclosed to recipient without restriction on disclosure. Upon written request from either party after completion of the work provided for hereunder or other termination of this Agreement each party will return to the other party any documents, or copies thereof, or any product samples, containing or constituting Confidential Information disclosed to or generated by either party in connection with this Agreement.

15. All notices or communications given hereunder by one party to the other shall be sent by hand or by first class prepaid registered or recorded delivery post or by facsimile addressed to such party as follows:

If to Pfizer:

	Pfizer, Inc.
	Attention: President, Animal Health
	5 Giralda Farms
	Madison, New Jersey 07940-1027

If to WALCO:

	Walco International, Inc.
	7 Village Circle, Suite 200
	Westlake, TX 76262

Either party may change its address by giving written notice to the other party.

16. This Agreement shall be effective as of January 1, 2011 and shall continue in force until December 31, 2011. This Agreement may be terminated by either party upon thirty (30) days prior written notice. Such termination may be without cause. This Agreement may be terminated immediately by either party upon written notice in the event of a material breach by the other. In the event WALCO takes any action that harms or damages the interests of Pfizer or the Products, other than where supported by sound

factual evidence, including, but not limited to, the diversion of Products and statements of false information, Pfizer may terminate this Agreement immediately upon written notice.

17. This Agreement shall be governed by the laws of the State of New York applicable to contracts made and performed therein. This Agreement is not assignable without the express written consent of the other party, and may be modified or amended only in writing signed by both parties.

18. This Agreement and documents referred to herein embody the entire understanding between the parties hereto, will supersede prior agreements relating to the Products. No activities conducted pursuant to this Agreement or related thereto, including but not limited to the future planning activities of the parties, shall be deemed to give rise to any obligations on the part of either party other than as expressly provided for herein.

IN WITNESS WHEREOF, intending to be legally bound, the parties have executed this Agreement.

Walco International, Inc.		Pfizer Inc.

By	/s/ Damian Olthoff	By	/s/ Clinton A. Lewis, Jr.
Damian Othoff		Clinton A. Lewis, Jr.
General Counsel		President, U.S. Operations
		Pfizer Animal Health

Date February 2, 2011		Date February 28, 2011

SCHEDULE A

FEE ELIGIBLE PRODUCTS

2011 Leaders’ Edge RSA Eligibility List

SKU

ITEM
DESCRIPTION

SIZE

RSA
ELIGIBLE

RSA (Sales
to LE Vets
& Animal
Health
Accounts)

RSA
(Sales to
Strategic
Producers)

RSA Sales
to LE
Producers

CATTLE-BIOLOGICALS

4252

Bovi-Shield® BRSV

/*/

4256

Bovi-Shield BRSV

/*/

5194

Bovi-Shield GOLD® 4

/*/

5195

Bovi-Shield GOLD 4

/*/

5199

Bovi-Shield GOLD® 5

/*/

5196

Bovi-Shield GOLD 5

/*/

5197

Bovi-Shield GOLD 5

/*/

5321

Bovi-Shield GOLD® FP® 5

/*/

5322

Bovi-Shield GOLD FP 5

/*/

5114

Bovi-Shield GOLD FP 5 L5

/*/

5323

Bovi-Shield GOLD® FP® 5 L5

/*/

5324

Bovi-Shield GOLD FP 5 L5

/*/

5325

Bovi-Shield GOLD FP 5 L5

/*/

5116

Bovi-Shield GOLD FP 5 VL5

/*/

5326

Bovi-Shield GOLD® FP® 5 VL5

/*/

5327

Bovi-Shield GOLD FP 5 VL5

/*/

5044

Bovi-Shield GOLD® FP® 5L5 HB

/*/

5253

Bovi-Shield GOLD FP 5 L5 HB

/*/

5254

Bovi-Shield GOLD FP 5 L5 HB

/*/

5255

Bovi-Shield GOLD® FP® 5 VL5 HB

/*/

5256

Bovi-Shield GOLD FP 5 VL5 HB

/*/

5267

Bovi-Shield GOLD® BVD

/*/

5268

Bovi-Shield GOLD BVD

/*/

5269

Bovi-Shield GOLD® IBR-BVD

/*/

5191

Bovi-Shield GOLD® IBR-BVD

/*/

4179

Bovi-Shield® IBR

/*/

4002

Calf-Guard®

/*/

4143

CattleMaster® 4+VL5

/*/

4144

CattleMaster 4+VL5

/*/

4145

CattleMaster 4+VL5

/*/

5094

CattleMaster® GOLD™ FP® 5

/*/

5095

CattleMaster GOLD FP 5

/*/

5096

CattleMaster GOLD FP 5

/*/

5124

CattleMaster® GOLD™ FP® 5 L5

/*/

5125

CattleMaster GOLD FP 5 L5

/*/

5126

CattleMaster GOLD FP 5 L5

/*/

1434

E.coli Bacterin- J-5™ Strain

/*/

1435

E.coli Bacterin- J-5 Strain

/*/

5263

INFORCE™3

/*/

5264

INFORCE 3

/*/

5265

INFORCE 3

/*/

5266

INFORCE 3

/*/

4475

Leptoferm-5®

/*/

4477

Leptoferm-5

/*/

4988

One Shot®

/*/

4991

One Shot

/*/

4993

One Shot

/*/

5074

One Shot Ultra® 7

/*/

5075

One Shot Ultra 7

/*/

5076

One Shot Ultra® 8

/*/

5077

One Shot Ultra 8

/*/

5328

PregGuard® GOLD FP® 10

/*/

5329

PregGuard GOLD FP 10

/*/

4308

Resvac® 4/Somubac®

/*/

4307

Resvac 4/Somubac

/*/

5331

ScourGuard® 4K

/*/

5332

ScourGuard 4K

/*/

5333

ScourGuard® 4KC

/*/

5334

ScourGuard 4KC

/*/

4255

Somubac®

/*/

4254

Somubac

/*/

5088

Spirovac®

/*/

5090

Spirovac

/*/

5200

Spirovac® L5

/*/

5201

Spirovac L5

/*/

5202

Spirovac® VL5

/*/

5203

Spirovac VL5

/*/

4890

StayBred™ VL5

/*/

4892

StayBred VL5

/*/

4904

TSV-2®

/*/

4909

TSV-2

/*/

4912

TSV-2

/*/

4913

TSV-2

/*/

4381

Ultrabac® 7

/*/

4379

Ultrabac 7

/*/

4380

Ultrabac 7

200

/*/

4384

Ultrabac® 7/Somubac®

/*/

4382

Ultrabac 7/Somubac

/*/

4383

Ultrabac 7/Somubac

200

/*/

4387

Ultrabac-8®

/*/

4385

Ultrabac-8

/*/

4386

Ultrabac-8

200

/*/

4388

Ultrabac® CD

/*/

4371

Ultrabac CD

/*/

5062

UltraChoice® 7

/*/

5063

UltraChoice 7

/*/

5064

UltraChoice 7

250

/*/

5065

UltraChoice® 8

/*/

5066

UltraChoice 8

/*/

5067

UltraChoice 8

250

/*/

5061

UltraChoice® CD

/*/

4937

Vibrin®

/*/

5330

SolidBac® Pinkeye IR/PR®

1 Pouch of 50

/*/

5270

Salmonella NewPort Bacterial Extract

/*/

5271

Escherichia Coli Bacterial Extract

/*/

CATTLE-ANTI-INFECTIVES

8171

A180®

100 mL

/*/

8172

A180

250 mL

/*/

8448

Albon® Bolus

5 g x 50

/*/

8449

Albon Bolus

15 g x 12

/*/

8450

Albon Bolus

15 g x 50

/*/

8189

Draxxin® Injectable Solution

50 mL

/*/

8174

Draxxin Injectable Solution

100 mL

/*/

8175

Draxxin Injectable Solution

250 mL

/*/

8176

Draxxin Injectable Solution

500 mL

/*/

1506

Excede® Sterile Suspension

100 mL

/*/

1431

Excenel® RTU Sterile Suspension

100 mL

/*/

7959

Liquamycin® LA-200®

100 mL

/*/

7960

Liquamycin LA-200

250 mL

/*/

7961

Liquamycin LA-200

500 mL

/*/

1465

Naxcel® Sterile Powder

1 g

/*/

1466

Naxcel Sterile Powder

4 g

/*/

1463

Sterile Water

80 mL

/*/

1464

Sterile Water

20 mL

/*/

7948

Terramycin® Scour Tabs

250 mg, 24/btl

/*/

7949

Terramycin Scour Tabs

250 mg, 100/btl

/*/

CATTLE-LINCOMIX

1453

Lincomix® Soluble Powder

480 g

/*/

1436

Linco-Spectin®

20 mL

/*/

CATTLE-MASTITIS

1403

Albadry Plus®

/*/

1404

Albadry Plus

144

/*/

2004

Nolvasan® Teat Dip

1 gal

/*/

8169

Orbeseal®

144

/*/

1475

Pirsue® Sterile Solution

/*/

1476

Pirsue Sterile Solution

144

/*/

1480

Quartermaster®

/*/

1481

Quartermaster (Bulk Pack)

144

/*/

1507

Spectramast® LC

/*/

1510

Spectramast LC

144

/*/

1508

Spectramast® DC

/*/

1511

Spectramast DC

144

/*/

CATTLE-PARACITICIDES

7897

Dectomax® 1% Injectable

100 mL

/*/

8186

Dectomax 1% Injectable

200 mL

/*/

7899

Dectomax 1% Injectable

500 mL

/*/

7892

Dectomax® Pour-On

250 mL

/*/

7893

Dectomax Pour-On

1 L

/*/

7894

Dectomax Pour-On

2.5 L

/*/

7895

Dectomax Pour-On

5 L

/*/

7030

Durasect®

1 gal

/*/

7032

Durasect II

900 mL

/*/

8783

Valbazen®

500 mL

/*/

8784

Valbazen

1 L

/*/

8785

Valbazen

5 L

/*/

CATTLE-REPRODUCTION

1420

EAZI-Breed™ CIDR® Applicator

Applicator

/*/

1518

EAZI-Breed CIDR Green Applicator

Applicator

/*/

1421

EAZI-Breed CIDR Insert

Bag of 10

/*/

0135

EAZI-Breed™ CIDR® G Applicator (Sheep)

Applicator

/*/

1533

EAZI-Breed CIDR G Insert (Sheep)

Bag of 20

/*/

2001

Factrel®

20 mL

/*/

1455

Lutalyse® Sterile Solution

30 mL

/*/

1504

Lutalyse Sterile Solution

100 mL

/*/

2003

Nolvalube®

8 lb

/*/

CATTLE-OTHER PHARMACEUTICALS

8152

Entrolyte® H.E.

178 g

/*/

2002

Hog & Cattle Vitamins & Electrolytes

8 oz

/*/

1478

Predef® 2X

100 mL

/*/

8112

Re-Sorb®

/*/

8142

Re-Sorb

/*/

8620

Therabloat®

2 oz

/*/

CATTLE-PRODUCTION

1458

MGA® 200 Premix

50 lb bag

/*/

1459

MGA® 500 Liquid Premix

40 lb drum

/*/

2016

Synovex® C

Box(10-10 ds Clips)

/*/

2014

Synovex C

Display(20 x 2-10 ds Clips)

/*/

2017

Synovex® Choice

Box(10-10 ds Clips)

/*/

2018

Synovex® H

Box(10-10 ds Clips)

/*/

2019

Synovex® Plus

Box(10-10 ds Clips)

/*/

2022

Synovex® S

Box(10-10 ds Clips)

/*/

DAIRY GENOMICS

PAG3KDB

Brown Swiss 3K Core Traits

—

/*/

PAG3KDH

Holstein 3K Core Traits

—

/*/

PAG3KDJ

Jersey 3K Core Traits

—

/*/

PAGR

Dairy Red Carrier Test

—

/*/

BEEF GENOMICS

PAGHDA

High Density 50 K Angus

—

/*/

PAGGST

GeneSTAR Combined Paned

—

/*/

PAGB

GeneSTAR Black

—

/*/

GENETIC CONDITIONS

PAGDEFAM

Anthrogryposis Mulitplex

—

/*/

PAGDEFNH

Neuro Hydrocephalus

—

/*/

PAGDEFAMNH

AM and NH Combined

—

/*/

PAGDEFCA

Contractural Arachnodactyly

—

/*/

PAGDEFIE

Idiopathic Epilepsy

—

/*/

PAGDEFMA

Alpha-Mannisodosis

—

/*/

PAGDEFOS

Osteopetrosis

—

/*/

PAGDEFPH

Pulmonary Hyperplasia Anasarca

—

/*/

PAGDEFTH

Tibial Hemimelia

—

/*/

PAGDEFPHTH

PH and TH

—

/*/

PARENT VERIFICATION

PAGPSNP

SireTRACE (SNP)

—

/*/

SWINE RESPIRATORY BIOLOGICALS

5223

FluSure XP®

/*/

5224

FluSure XP

250

/*/

5042

FluSure® Pandemic

/*/

5043

FluSure Pandemic

250

/*/

5219

FluSure XP®/FarrowSure® GOLD

/*/

5220

FluSure XP/FarrowSure GOLD

250

/*/

5221

FluSure XP®/FarrowSure® GOLD Plus B

/*/

5227

FluSure XP®/RespiSure®

/*/

5231

FluSure XP®/RespiSure-ONE®

/*/

5225

FluSure XP®/ER Bac Plus®

/*/

5233

FluSure XP®/RespiSure-ONE®/ER Bac Plus®

/*/

5001

RespiSure-ONE® (to be disc)

/*/

5002

RespiSure-ONE (to be disc)

250

/*/

5003

RespiSure-ONE (to be disc)

500

/*/

5260

RespiSure-ONE®

/*/

5261

RespiSure-ONE

250

/*/

5262

RespiSure-ONE

500

/*/

5166

RespiSure-ONE®/ER Bac Plus®

/*/

5167

RespiSure-ONE/ER Bac Plus

250

/*/

5168

RespiSure-ONE/ER Bac Plus

500

/*/

4606

RespiSure®

/*/

4618

RespiSure

250

/*/

4589

RespiSure

500

/*/

5169

RespiSure®/ER Bac Plus®

/*/

5170

RespiSure/ER Bac Plus

250

/*/

5171

RespiSure/ER Bac Plus

500

/*/

2238

Suvaxyn® RespiFend® MH/HPS

/*/

2239

Suvaxyn RespiFend MH/HPS

125

/*/

2224

Suvaxyn® PCV2

/*/

2225

Suvaxyn PCV2

250

/*/

5041

ER Bac® Plus

250

/*/

2214

Suvaxyn® E - oral

100

/*/

2215

Suvaxyn E - oral

250

/*/

2216

Suvaxyn E - oral

500

/*/

SWINE REPRODUCTIVE BIOLOGICALS

5213

ER Bac® L5 GOLD

/*/

5204

FarrowSure® GOLD

/*/

5248

FarrowSure GOLD

250

/*/

5206

FarrowSure® GOLD B

/*/

4402

LitterGuard®

/*/

4410

LitterGuard® LT-C

/*/

4452

LitterGuard LT-C

250

/*/

SWINE LARGE ANIMAL VIALS

8189

Draxxin® Injectable Solution

50 mL

/*/

8174

Draxxin Injectable Solution

100 mL

/*/

8175

Draxxin Injectable Solution

250 mL

/*/

8176

Draxxin Injectable Solution

500 mL

/*/

1505

EXCEDE® for Swine

100 mL

/*/

1431

Excenel® RTU Sterile Suspension

100 mL

/*/

1436

Linco-Spectin®

20 mL

/*/

1450

Lincomix® 100 mg Injectable

100 mL

/*/

1451

Lincomix 300 mg Injectable

100 mL

/*/

1455

Lutalyse® Sterile Solution

30 mL

/*/

1504

Lutalyse Sterile Solution

100 mL

/*/

1465

Naxcel® Sterile Powder

1 g

/*/

1466

Naxcel Sterile Powder

4 g

/*/

1463

Sterile Water

80 mL

/*/

1478

Predef® 2X

100 mL

/*/

7897

Dectomax® 1% Injectable

100 mL

/*/

8186

Dectomax 1% Injectable

200 mL

/*/

7899

Dectomax 1% Injectable

500 mL

/*/

7959

Liquamycin® LA-200®

100 mL

/*/

7960

Liquamycin LA-200

250 mL

/*/

7961

Liquamycin LA-200

500 mL

/*/

1453

Lincomix Soluble Powder

480 g

/*/

1454

LS 50

75 g

/*/

SWINE-FEED MEDICATIONS

1447

Lincomix® 20

50 lb

/*/

1448

Lincomix® 50

50 lb

/*/

SCHEDULE B

LIST OF STRATEGIC ACCOUNTS

“PARTICIPATING CUSTOMERS (Veterinarians, Dealers, Producers, and Strategic Producers) will be clearly identified with current updates within the Leaders’ Edge Enrollment Notifications that are regularly posted to the Pfizer AH Partners website www.pfizerahartners.com.

Narc ID	Name	Address	City	State
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

SCHEDULE C

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE

BIOLOGICALS
4252	Bovi-Shield® BRSV	10	100	/*/
4256	Bovi-Shield BRSV	50	20	/*/
5194	Bovi-Shield GOLD® 4	10	100	/*/
5195	Bovi-Shield GOLD 4	50	20	/*/
5199	Bovi-Shield GOLD 5	5	200	/*/
5196	Bovi-Shield GOLD 5	10	100	/*/
5197	Bovi-Shield GOLD 5	50	20	/*/
5321	Bovi-Shield GOLD FP® 5	10	100	/*/
5322	Bovi-Shield GOLD FP 5	50	20	/*/
5323	Bovi-Shield GOLD FP 5 L5	5	200	/*/
5324	Bovi-Shield GOLD FP 5 L5	10	100	/*/
5325	Bovi-Shield GOLD FP 5 L5	50	20	/*/
5326	Bovi-Shield GOLD FP 5 VL5	10	100	/*/
5327	Bovi-Shield GOLD FP 5 VL5	50	20	/*/
5044	Bovi-Shield GOLD FP 5 L5 HB	5	200	/*/
5253	Bovi-Shield GOLD FP 5 L5 HB	10	100	/*/
5254	Bovi-Shield GOLD FP 5 L5 HB	50	20	/*/
5255	Bovi-Shield GOLD FP 5 VL5 HB	10	40	/*/
5256	Bovi-Shield GOLD FP 5 VL5 HB	50	20	/*/
5267	Bovi-Shield GOLD BVD	10	100	/*/
5268	Bovi-Shield GOLD BVD	50	20	/*/
5269	Bovi-Shield GOLD IBR-BVD	10	100	/*/
5191	Bovi-Shield GOLD IBR-BVD	50	20	/*/
4179	Bovi-Shield IBR	50	20	/*/
4002	CALF-GUARD®	1	750	/*/
4143	CattleMaster® 4+VL5	5	100	/*/
4144	CattleMaster 4+VL5	10	40	/*/
4145	CattleMaster 4+VL5	25	40	/*/
5094	CattleMaster GOLD FP 5	5	100	/*/
5095	CattleMaster GOLD FP 5	10	40	/*/
5096	CattleMaster GOLD FP 5	25	40	/*/
5124	CattleMaster GOLD FP 5 L5	5	100	/*/
5125	CattleMaster GOLD FP 5 L5	10	40	/*/
5126	CattleMaster GOLD FP 5 L5	25	40	/*/
5271	E. Coli Bacterial Extract vaccine with SRP® technology	50	72	/*/

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE
5263	INFORCE™ 3	1	750	/*/
5264	INFORCE 3	10	100	/*/
5265	INFORCE 3	25	40	/*/
5266	INFORCE 3	50	20	/*/
BIOLOGICALS
4475	Leptoferm-5®	10	100	/*/
4477	Leptoferm-5	50	100	/*/
4988	ONE SHOT®	5	200	/*/
4991	ONE SHOT	10	100	/*/
4993	ONE SHOT	50	20	/*/
5074	ONE SHOT ULTRA® 7	10	100	/*/
5075	ONE SHOT ULTRA 7	50	20	/*/
5076	ONE SHOT ULTRA 8	10	100	/*/
5077	ONE SHOT ULTRA 8	50	20	/*/
5328	PregGuard GOLD FP® 10	10	100	/*/
5329	PregGuard GOLD FP 10	50	20	/*/
4308	RESVAC® 4/SOMUBAC®	10	100	/*/
4307	RESVAC 4/SOMUBAC	50	20	/*/
5270	Salmonella Newport Bacterial Extract vaccine with SRP® technology	50	72	/*/
5331	ScourGuard® 4K	10	100	/*/
5332	ScourGuard 4K	50	100	/*/
5333	ScourGuard 4KC	10	100	/*/
5334	ScourGuard 4KC	50	100	/*/
5330	SolidBAC® Pinkeye IR/PR®	1 Pouch of 50	20 Pouches of 50	/*/
4255	SOMUBAC®	10	100	/*/
4254	SOMUBAC	50	100	/*/
5088	SPIROVAC®	10	100	/*/
5090	SPIROVAC	50	100	/*/
5200	SPIROVAC L5	10	100	/*/
5201	SPIROVAC L5	50	100	/*/
5202	SPIROVAC VL5	10	80	/*/
5203	SPIROVAC VL5	50	20	/*/
4890	STAYBRED® VL5	10	100	/*/
4892	STAYBRED VL5	50	100	/*/
4904	TSV-2®	1	750	/*/
4909	TSV-2	10	100	/*/
4912	TSV-2	25	40	/*/

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE
4913	TSV-2	50	20	/*/
4381	ULTRABAC® 7	10	192	/*/
4379	ULTRABAC 7	50	48	/*/
4380	ULTRABAC 7	200	12	/*/
4384	ULTRABAC 7/SOMUBAC	10	192	/*/
4382	ULTRABAC 7/SOMUBAC	50	48	/*/
4383	ULTRABAC 7/SOMUBAC	200	12	/*/
4387	ULTRABAC-8®	10	192	/*/
BIOLOGICALS
4385	ULTRABAC-8	50	48	/*/
4386	ULTRABAC-8	200	12	/*/
4388	ULTRABAC CD	10	100	/*/
4371	ULTRABAC CD	50	100	/*/
5062	ULTRACHOICE® 7	10	100	/*/
5063	ULTRACHOICE 7	50	100	/*/
5064	ULTRACHOICE 7	250	12	/*/
5065	ULTRACHOICE 8	10	100	/*/
5066	ULTRACHOICE 8	50	100	/*/
5067	ULTRACHOICE 8	250	12	/*/
5061	ULTRACHOICE CD	50	100	/*/
1434	UPJOHN J-5 BACTERIN™	20	42	/*/
1435	UPJOHN J-5 BACTERIN	50	36	/*/
4937	VIBRIN®	50	100	/*/
ANTI-INFECTIVES
8171	A180® (Rx)†	100 mL	12	/*/
8172	A180 (Rx)†	250 mL	6	/*/
8448	ALBON® Bolus	5 g x 50	12	/*/
8449	ALBON Bolus	15 g x 12	12	/*/
8450	ALBON Bolus	15 g x 50	6	/*/
8189	DRAXXIN® Injectable Solution (Rx)†	50 mL	40	/*/
8174	DRAXXIN Injectable Solution (Rx)†	100 mL	12	/*/
8175	DRAXXIN Injectable Solution (Rx)†	250 mL	6	/*/
8176	DRAXXIN Injectable Solution (Rx)†	500 mL	6	/*/
1506	EXCEDE® Sterile Suspension (Rx)†	100 mL	10	/*/
1431	EXCENEL® RTU Sterile Suspension (Rx)†	100 mL	10	/*/
7959	LIQUAMYCIN® LA-200®	100 mL	24	/*/
7960	LIQUAMYCIN LA-200	250 mL	12	/*/
7961	LIQUAMYCIN LA-200	500 mL	6	/*/

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE
1465	NAXCEL® Sterile Powder (Rx)†	1 g	48	/*/
1466	NAXCEL Sterile Powder (Rx)†	4 g	36	/*/
1463	Sterile Water‡	80 mL	72	/*/
1464	Sterile Water	20 mL	288	/*/
7948	TERRAMYCIN® Scour Tabs	250 mg, 24/btl	12	/*/
7949	TERRAMYCIN Scour Tabs	250 mg, 100/btl	12	/*/
LINCOMIX
1453	LINCOMIX® Soluble Powder	480 g	5	/*/
1436	LINCO-SPECTIN® (Rx)†	20 mL	72	/*/
MASTITIS
1403	ALBADRY PLUS®**	Box (12 syringes)	12	/*/
1404	ALBADRY PLUS **	Pail (144 syringes)	1	/*/
2004	Nolvasan® Teat Dip	1 gal	4	/*/
8169	ORBESEAL®	Pail (144 syringes)	1	/*/
1475	PIRSUE® Sterile Solution (Rx)†	Box (12 syringes)	12	/*/
1476	PIRSUE Sterile Solution (Rx)†	Pail (144 syringes)	1	/*/
1480	QUARTERMASTER® (Rx)†	Box (12 syringes)	12	/*/
1481	QUARTERMASTER (BULK PACK) (Rx)†	Pail (144 syringes)	1	/*/
1507	SPECTRAMAST® LC (Rx)†	Box (12 syringes)	12	/*/
1510	SPECTRAMAST LC (Rx)†	Pail (144 syringes)	1	/*/
1508	SPECTRAMAST DC (Rx)†	Box (12 syringes)	12	/*/
1511	SPECTRAMAST DC (Rx)†	Pail (144 syringes)	1	/*/
PARASITICIDES
7897	DECTOMAX® 1% Injectable	100 mL	24	/*/
8186	DECTOMAX 1% Injectable	200 mL	12	/*/
7899	DECTOMAX 1% Injectable	500 mL	6	/*/
7892	DECTOMAX Pour-On	250 mL	10	/*/
7893	DECTOMAX Pour-On	1 L	10	/*/
7894	DECTOMAX Pour-On	2.5 L	4	/*/

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE
7895	DECTOMAX Pour-On	5 L	2	/*/
7030	DURASECT®	1 gal	4	/*/
7032	DURASECT II	900 mL	6	/*/
8783	VALBAZEN®	500 mL	12	/*/
8784	VALBAZEN	1 L	12	/*/
8785	VALBAZEN	5 L	2	/*/
REPRODUCTION
1421	Eazi-Breed™ CIDR® Insert	Bag of 10	50 Bags of 10	/*/
1420	Eazi-Breed CIDR Applicator §	Applicator	50	/*/
1518	Eazi-Breed CIDR Green Applicator §	Applicator	50	/*/
0135	Eazi-Breed CIDR G Applicator (Sheep) §	Applicator	100	/*/
1533	Eazi-Breed CIDR G Insert (Sheep)	Bag of 20	5 Bags of 20	/*/
2001	FACTREL® (Rx)†	20 mL	24	/*/
1455	LUTALYSE® Sterile Solution (Rx)†	30 mL	48	/*/
1504	LUTALYSE Sterile Solution (Rx)†	100 mL	10	/*/
2003	Nolvalube®	8 lb	4	/*/
PRODUCTION
1458	MGA® 200 Premix	50 lb Bag	1	/*/
1459	MGA 500 Liquid Premix	40 lb Drum	1	/*/
2016	SYNOVEX® C	Box (10-10 ds Clips)	50	/*/
2014	SYNOVEX C	Display (20 boxes x 2-10 ds Clips)	10	/*/
2018	SYNOVEX® H	Box (10-10 ds Clips)	50	/*/
2022	SYNOVEX® S	Box (10-10 ds Clips)	50	/*/
2017	SYNOVEX CHOICE®	Box (10-10 ds Clips)	50	/*/
2019	SYNOVEX PLUS®	Box (10-10 ds Clips)	10	/*/
OTHER PHARMACEUTICALS
8152	ENTROLYTE® H.E.	178 g	40	/*/
2002	Hog & Cattle Vitamins & Electrolytes	8 oz	40	/*/

ITEM #	ITEM DESCRIPTION	SIZE	CASE QUANTITY	SUGGESTED RETAIL PRICE
1478	PREDEF® 2X (Rx)†	100 mL	6	/*/
8112	RE-SORB®	12	6	/*/
8142	RE-SORB	72	1	/*/
8620	THERABLOAT®	2 oz	144	/*/
DAIRY GENOMICS
PAG3KDB	CLARIFIDE™ for Brown Swiss	N/A	N/A	/*/
PAG3KDH	CLARIFIDE for Holstein	N/A	N/A	/*/
PAG3KDJ	CLARIFIDE for Jersey	N/A	N/A	/*/
PAGR	Red Carrier Test	N/A	N/A	/*/
BEEF GENOMICS
PAGB	Coat Color (black)	N/A	N/A	/*/
PAGGST	GeneSTAR®	N/A	N/A	/*/
PAGHDA	HD 50 K Angus	N/A	N/A	/*/
GENETIC CONDITIONS
PAGDEFMA	Alpha-Mannosidosis (MA)	N/A	N/A	/*/
PAGDEFAMNH	AM + NH	N/A	N/A	/*/
PAGDEFAM	Arthrogryposis Multiplex (AM)	N/A	N/A	/*/
PAGDEFCA	Contractural Arachnodactyly (CA)	N/A

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/
/*/	/*/	/*/	/*/	/*/

Animal Health International, Inc. 8-K/A